Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Foundation to host joint webinar on the 2024 Access to Medicine Index with Medicines Patent Pool and the Ecumenical Pharmaceutical Network

The Access to Medicine Foundation is co-hosting a webinar on the 2024 Access to Medicine Index with Medicines Patent Pool (MPP) and the Ecumenical Pharmaceutical Network (EPN). The session will offer insights into industry trends, company-specific performances, and discuss strategies to enhance access to essential medicines in low- and middle-income countries.

Date

10 April 2025

Direct links

Register for the webinar

DATE

Thursday, 10 April 2025

TIME

14:00-16:00 CEST

FORMAT

Virtual. Register to attend here.

Access to medicine in sub-Saharan Africa remains a critical issue, with numerous barriers hindering equitable healthcare. The high cost of essential medicines is one of the main challenges in low- and middle-income countries (LMICs), creating a gap between the availability of these medicines and people's ability to afford them. 

To address this disparity and strengthen their collective efforts, the Access to Medicine Foundation, Medicines Patent Pool (MPP), and the Ecumenical Pharmaceutical Network (EPN) are partnering to host a joint webinar. The webinar will share key findings from the 2024 Access to Medicine Index and provide expert perspectives on the evolving landscape of access to medicine. 

During the webinar, the Foundation’s team will present detailed findings from the 2024 Index, including industry trends and company-specific performance. The team will emphasise the Index’s importance as a tool for accountability in the pharmaceutical sector. Following the presentation, the team will also engage in panel discussion and Q&A session, helping fellow attendees to delve deeper into the implications of the 2024 Index findings and exchange insights on the opportunities and challenges pharmaceutical companies face in advancing health equity and access in LMICs. 

Resource Centre

Read the key findings from 2024 Access to Medicine Index
Key findings

Pharma companies are taking steps to address access in low-income countries, but significant gaps remain

19 November 2024
Key findings

Patients in low- and middle-income countries largely left out of clinical trials, limiting access to new treatments

19 November 2024
Key findings

Efforts to ramp up wider local availability of medicines through voluntary licensing and technology transfers are limited

19 November 2024

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved